Senolytics alleviate cyclophosphamide-induced premature ovarian insufficiency by eliminating senescent cells
{{output}}
Alkylating agents, particularly cyclophosphamide (CY), are known for their high toxicity, which can lead to iatrogenic premature ovarian insufficiency (POI) and infertility in young cancer survivors. Currently, effective prevention and treatment strategies rem... ...